National trend of utilization, clinical and economic outcomes of transcatheter aortic valve replacement among patients with chronic obstructive pulmonary disease

References

• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;129:e521–e643.
   PubMed Web of Science ®Google Scholar
• Condado JF, Haider MN, Lerakis S, et al. Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease? Cathet Cardiovasc Intervent. 2017;89:775–780.
   PubMed Web of Science ®Google Scholar
• Bavaria JE, Szeto WY, Roche LA, et al. The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals. Ann Thorac Surg. 2011;92:2072–2077.
   PubMed Web of Science ®Google Scholar
• Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122:S37–S42.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607.
   PubMed Web of Science ®Google Scholar
• Dvir D, Waksman R, Barbash IM, et al. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (Placement of AoRTic TraNscathetER valve). J Am Coll Cardiol. 2014;63:269–279.
   PubMed Web of Science ®Google Scholar
• Gotzmann M, Knoop H, Ewers A, et al. Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: insights from spirometry and body plethysmography. Am Heart J. 2015;170:837.e1–842.e1.
   Web of Science ®Google Scholar
• Suri RM, Gulack BC, Brennan JM, et al. Outcomes of patients with severe chronic lung disease who are undergoing transcatheter aortic valve replacement. Ann Thorac Surg. 2015;100:2136–2146.
   PubMed Web of Science ®Google Scholar
• Chopard R, Meneveau N, Chocron S, et al. Impact of chronic obstructive pulmonary disease on valve academic research consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry). Am J Cardiol. 2014;113:1543–1549.
   PubMed Web of Science ®Google Scholar
• Henn MC, Zajarias A, Lindman BR, et al. Preoperative pulmonary function tests predict mortality after surgical or transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016;151:578.e2–586.e2.
   Web of Science ®Google Scholar
• Ando T, Adegbala O, Akintoye E, et al. Is transcatheter aortic valve replacement better than surgical aortic valve replacement in patients with chronic obstructive pulmonary disease? A nationwide inpatient sample analysis. J Am Heart Assoc. 2018;7(7):e008408.
   PubMed Web of Science ®Google Scholar
• Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom transcatheter aortic valve implantation) registry. J Am Coll Cardiol. 2011;58:2130–2138.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–1875.
   PubMed Web of Science ®Google Scholar
• Unbehaun A, Pasic M, Drews T, et al. Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic valve implantation. Ann Thorac Surg. 2011;92:1315–1323.
   PubMed Web of Science ®Google Scholar
• Crestanello JA, Popma JJ, Adams DH, et al. Long-term health benefit of TAVR in patients with chronic lung disease. JACC Cardiovasc Interv. 2017;10(22):2283–2293.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. NIS overview [Internet] [updated 2016; cited 2017 Mar 21]. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp
   Google Scholar
• Agency for Healthcare Research and Quality. NIS database documentation [Internet] [updated 2016; cited 2017 Mar 21]. Available from: https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp
   Google Scholar
• Cavailles A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22:454–475.
   PubMedGoogle Scholar
• Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63:487–492.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Clinical classifications software (CCS) for ICD-9-CM [Internet] [updated 2017; cited 2017 Mar 22]. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp
   Google Scholar
• Dhoble A, Bhise V, Nevah MI, et al. Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: a propensity matched analysis. Catheter Cardiovasc Interv. 2018;91(1):90–96.
   PubMed Web of Science ®Google Scholar
• Bhise V, Kanade P, Shantha GP, et al. Transcatheter and surgical aortic valve replacement in patients with end-stage renal disease. J Am Coll Cardiol. 2017;69:1875–1876.
   PubMed Web of Science ®Google Scholar
• Khera R, Cram P, Lu X, et al. Trends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012. JAMA Intern Med. 2015;175:941–950.
   PubMed Web of Science ®Google Scholar
• Mentias A, Faza NN, Raza MQ, et al. Management of symptomatic severe aortic stenosis in patient with very severe chronic obstructive pulmonary disease. Semin Thorac Cardiovasc Surg. 2016;28:783–790.
   PubMed Web of Science ®Google Scholar
• Melby SJ, Bess KM, Isbell KD, et al. Transcatheter aortic valve replacement program in the post-food and drug administration approval era: early outcomes at an academic medical center. Innovations (Phila). 2015;10:48–51.
   PubMedGoogle Scholar
• US Food and Drug Administration. FDA approves expanded indication for two transcatheter heart valves for patients at intermediate risk for death or complications associated with open-heart surgery. FDA News Release Web site [Internet] [updated 2016; cited 2017 Jun 11]. Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm517281.htm
   Google Scholar
• Brunt ME, Egorova NN, Moskowitz AJ. Propensity score-matched analysis of open surgical and endovascular repair for type B aortic dissection. Int J Vasc Med. 2011;2011:364046.
   PubMedGoogle Scholar
• Hanna N, Sun M, Trinh Q, et al. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series. Eur Urol. 2012;61:715–721.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374:704–711.
   PubMed Web of Science ®Google Scholar
• Forman DE, Fleg JL, Kitzman DW, et al. 6-Min Walk Test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol. 2012;60:2653–2661.
   PubMed Web of Science ®Google Scholar
• Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-Minute Walk Test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993;270:1702–1707.
   PubMed Web of Science ®Google Scholar
• Afilalo J, Eisenberg MJ, Morin J, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56:1668–1676.
   PubMed Web of Science ®Google Scholar
• Motloch LJ, Rottlaender D, Reda S, et al. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45–53.
   PubMed Web of Science ®Google Scholar
• Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5:461–467.
   PubMed Web of Science ®Google Scholar